Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
about
Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.Management of low risk prostate cancer-active surveillance and focal therapy.The oncologic role of local treatment in primary metastatic prostate cancer.Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features.Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials.Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.[Localized intermediate- to high-risk prostate cancer].
P2860
Q37214143-3A09800B-1BCF-469D-9DE4-79297AAF9FEFQ37605565-A120CDE1-FA41-4EB3-BF22-DE5C85451EB7Q37636973-FA773818-41CF-45C9-80F2-CAA30A5AA65BQ38211360-A7CB7328-DA76-41D3-82D2-BB7D95A3B5D0Q38226522-203E3F2F-7301-45AB-8D6D-ABE2D2C45988Q38746140-D0176B73-5C53-4A6A-AA85-F029569566EBQ38804659-6D5CF131-A63F-40DE-86CF-4D3DE8106906Q40875442-07C79675-505F-4295-8099-1419E62B3AE2Q41436143-972E7345-BC69-4831-82EB-DAD896D581BEQ42659138-0AB913DD-7618-4528-9BD8-ECF675204ECBQ48543708-71C70621-F9E8-42CE-9704-E2336C0D08F7Q49586737-561DA465-9FA6-4435-AB39-292077180F54Q53175999-4631D26F-36E1-4E70-93FA-5D9D26B70307
P2860
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mortality after prostate cance ...... py in men without comorbidity.
@en
Mortality after prostate cance ...... py in men without comorbidity.
@nl
type
label
Mortality after prostate cance ...... py in men without comorbidity.
@en
Mortality after prostate cance ...... py in men without comorbidity.
@nl
prefLabel
Mortality after prostate cance ...... py in men without comorbidity.
@en
Mortality after prostate cance ...... py in men without comorbidity.
@nl
P2093
P2860
P50
P1433
P1476
Mortality after prostate cance ...... py in men without comorbidity.
@en
P2093
Adam S Kibel
Andrew J Stephenson
Changhong Yu
Dorina Kallogjeri
Eric A Klein
Jay F Piccirillo
Jay P Ciezki
Jeff Michalski
Jennifer Haslag-Minoff
Robert L Grubb
P2860
P304
P356
10.1016/J.EURURO.2013.03.005
P407
P577
2013-03-13T00:00:00Z